导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.82% | 592/1050 |
| 近一周 | -1.10% | 482/1104 |
| 近一月 | -2.78% | 498/1103 |
| 近一季 | -16.75% | 900/1092 |
| 近半年 | -11.16% | 808/1070 |
| 近一年 | 10.56% | 358/1018 |
| 近两年 | 48.85% | 516/926 |
| 近三年 | 13.45% | 573/834 |
| 成立以来 | 7.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.53% 223/1070 |
26.45% 327/1101 |
- - |
- - |
| 2025 | 28.61% 495/1065 |
1.20% 709/1014 |
-0.66% 739/1038 |
21.54% 556/1050 |
5.25% 128/1065 |
| 2024 | -10.20% 769/1011 |
-11.64% 819/960 |
-1.90% 431/983 |
7.76% 789/991 |
-3.86% 591/1011 |
| 2023 | -18.49% 637/952 |
7.73% 179/880 |
-11.26% 794/895 |
-10.75% 611/915 |
-4.47% 448/952 |
| 2022 | -25.67% 517/867 |
-23.56% 687/773 |
10.75% 237/806 |
-16.32% 640/845 |
4.93% 211/867 |
| 2021 | -1.15% 367/740 |
-8.05% 448/580 |
16.34% 215/659 |
-9.34% 492/704 |
1.93% 358/740 |
| 2020 | 91.07% 55/554 |
7.01% 56/419 |
40.44% 23/466 |
6.03% 344/517 |
19.91% 120/554 |
| 2019 | 47.37% 171/410 |
23.48% 812/1149 |
0.66% 270/1231 |
13.03% 68/390 |
4.90% 341/410 |
| 2018 | -41.54% 279/349 |
- - |
- - |
- - |
-10.83% 372/1080 |
| 2017 | 5.23% 155/285 |
- - |
- - |
- - |
- - |
| 2016 | -35.08% 150/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中银新动力股票A VS. 东吴新产业精选股票A(580008) |